Debt-to-equity of Klotho Neurosciences, Inc. from 31 Mar 2023 to 30 Sep 2025

Taxonomy & unit: ratio: %
Description: Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary: Klotho Neurosciences, Inc. quarterly Debt-to-equity in % history and change rate from 31 Mar 2023 to 30 Sep 2025.
Klotho Neurosciences, Inc. Debt-to-equity for the quarter ending 30 Sep 2025 was 18%, a 99% decline year-over-year.

Debt-to-equity, Quarterly (%)

Debt-to-equity, YoY Quarterly Change (%)

Klotho Neurosciences, Inc. Quarterly Debt-to-equity (%)

Period	Value	YoY Chg	Change %	Date
Q3 2025	18%	-1882%	-99%	30 Sep 2025
Q2 2025	35%	-28218%	-100%	30 Jun 2025
Q1 2025	547%	+1093%		31 Mar 2025
Q4 2024	1075%	+1952%		31 Dec 2024
Q3 2024	1900%	+2517%		30 Sep 2024
Q2 2024	28252%	+28702%		30 Jun 2024
Q1 2024	-545%	-59%	-12%	31 Mar 2024
Q4 2023	-878%			31 Dec 2023
Q3 2023	-617%			30 Sep 2023
Q2 2023	-450%			30 Jun 2023
Q1 2023	-486%			31 Mar 2023

* An asterisk sign (*) next to the value indicates that the value is likely invalid.